Literature DB >> 20065135

APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.

Madhav Thambisetty1, Lori Beason-Held, Yang An, Michael A Kraut, Susan M Resnick.   

Abstract

OBJECTIVE: To study differences in longitudinal changes in regional cerebral blood flow (rCBF) between apolipoprotein E (APOE) epsilon4 carriers and noncarriers in nondemented older adults from the Baltimore Longitudinal Study of Aging using positron emission tomography in order to determine whether there are regionally specific longitudinal changes in rCBF in APOE epsilon4 carriers that might be related to its well-established role as a genetic risk factor for Alzheimer disease. DESIGN, SETTING, AND PARTICIPANTS: Using oxygen 15 ([(15)O])-labeled water positron emission tomography and voxel-based analysis, we compared changes in rCBF over an 8-year period between 29 nondemented APOE epsilon4 carriers and 65 noncarriers older than 55 years. Serial neuropsychological data were collected for all participants.
RESULTS: Widespread differences were observed in longitudinal change in rCBF between epsilon4 carriers and noncarriers. The predominant pattern was greater rCBF decline in epsilon4 carriers. These differences were observed in the frontal, parietal, and temporal cortices. The affected brain regions were those especially vulnerable to pathological changes in Alzheimer disease. Both epsilon4 carriers and noncarriers remained free of clinical diagnoses of dementia or mild cognitive impairment during the course of the study.
CONCLUSIONS: Our findings suggest that APOE epsilon4-mediated risk for Alzheimer disease is associated with widespread decline in rCBF over time that precedes the onset of dementia. Accelerated rates of decline in brain function in APOE epsilon4 carriers may contribute to an increased risk for Alzheimer disease and a younger age at onset.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065135      PMCID: PMC2856443          DOI: 10.1001/archneurol.2009.913

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  27 in total

1.  Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

Authors:  M J de Leon; A Convit; O T Wolf; C Y Tarshish; S DeSanti; H Rusinek; W Tsui; E Kandil; A J Scherer; A Roche; A Imossi; E Thorn; M Bobinski; C Caraos; P Lesbre; D Schlyer; J Poirier; B Reisberg; J Fowler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

Authors:  M Morishima-Kawashima; N Oshima; H Ogata; H Yamaguchi; M Yoshimura; S Sugihara; Y Ihara
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.

Authors:  H Soininen; K Partanen; A Pitkänen; M Hallikainen; T Hänninen; S Helisalmi; A Mannermaa; M Ryynänen; K Koivisto; P Riekkinen
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

6.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

Authors:  G W Small; L M Ercoli; D H Silverman; S C Huang; S Komo; S Y Bookheimer; H Lavretsky; K Miller; P Siddarth; N L Rasgon; J C Mazziotta; S Saxena; H M Wu; M S Mega; J L Cummings; A M Saunders; M A Pericak-Vance; A D Roses; J R Barrio; M E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

8.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Authors:  P Tiraboschi; L A Hansen; E Masliah; M Alford; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Authors:  Keith D Coon; Amanda J Myers; David W Craig; Jennifer A Webster; John V Pearson; Diane Hu Lince; Victoria L Zismann; Thomas G Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Douglas G Walker; Rivka Ravid; Christopher B Heward; Joseph Rogers; Andreas Papassotiropoulos; Eric M Reiman; John Hardy; Dietrich A Stephan
Journal:  J Clin Psychiatry       Date:  2007-04       Impact factor: 4.384

View more
  94 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

Authors:  Robert D Bell; Ethan A Winkler; Itender Singh; Abhay P Sagare; Rashid Deane; Zhenhua Wu; David M Holtzman; Christer Betsholtz; Annika Armulik; Jan Sallstrom; Bradford C Berk; Berislav V Zlokovic
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

Review 3.  The cognitive neuroscience of ageing.

Authors:  Cheryl Grady
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

Review 4.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.

Authors:  Katherine J Bangen; Khaled Restom; Thomas T Liu; Christina E Wierenga; Amy J Jak; David P Salmon; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Tyler A Zink; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12-31       Impact factor: 2.035

7.  Higher cardiovascular fitness level is associated with lower cerebrovascular reactivity and perfusion in healthy older adults.

Authors:  Brittany Intzandt; Dalia Sabra; Catherine Foster; Laurence Desjardins-Crépeau; Richard D Hoge; Christopher J Steele; Louis Bherer; Claudine J Gauthier
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-25       Impact factor: 6.200

8.  Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.

Authors:  Jun Hua; SeungWook Lee; Nicholas I S Blair; Michael Wyss; Jiri M G van Bergen; Simon J Schreiner; Sonja M Kagerer; Sandra E Leh; Anton F Gietl; Valerie Treyer; Alfred Buck; Roger M Nitsch; Klaas P Pruessmann; Hanzhang Lu; Peter C M Van Zijl; Marilyn Albert; Christoph Hock; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2019-01-10       Impact factor: 4.673

9.  Fitness, independent of physical activity is associated with cerebral blood flow in adults at risk for Alzheimer's disease.

Authors:  Ryan J Dougherty; Elizabeth A Boots; Jacob B Lindheimer; Aaron J Stegner; Stephanie Van Riper; Dorothy F Edwards; Catherine L Gallagher; Cynthia M Carlsson; Howard A Rowley; Barbara B Bendlin; Sanjay Asthana; Bruce P Hermann; Mark A Sager; Sterling C Johnson; Ozioma C Okonkwo; Dane B Cook
Journal:  Brain Imaging Behav       Date:  2020-08       Impact factor: 3.978

Review 10.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.